H.U. Group Central Research Institute
VC Fund
Tokyo, Japan
H.U. Group Central Research Institute is a VC fund in Tokyo focused on Medical and Health Care. H.U. Group contributes to creating a healthy and prosperous society and promoting global healthcare services.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries H.U. Group Central Research Institute invests in
Stages H.U. Group Central Research Institute invests in
Countries H.U. Group Central Research Institute invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Shigekazu Takeuchi
|
|||
4 more contacts available
Investment Focus
Industry
- Medical 3 (60%)
- Health Care 3 (60%)
- Apps 2 (40%)
- Consulting 2 (40%)
- Biotechnology 2 (40%)
Stage
- Venture - Series Unknown 3 (60%)
- Funding Round 2 (40%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Shigekazu Takeuchi
Chairman, President, and CEO
|
Chairman, President, and CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
MICIN
|
MICIN is a medical IT company that offers a free app for patient charts, billing, and video chatting between doctors and patients. | Venture - Series Unknown / Jan 26, 2021 | |
Catalyna
|
Catalyna is a Japan-based company that provides its users with system development and handing solutions. It was founded in 2015 and is headquartered in Tokyo, Japan. | Venture - Series Unknown / Jun 25, 2020 | |
AGREE
|
AGREE is an application developer and operator for medical consultation. Its product is the medical consultation application, LEBER. It allows its users to consult with a doctor on their smartphone 24/7. It was founded in 2017 and is headquartered in Tsukuba, Ibaraki Prefecture, Japan. | $3.9M / Venture - Series Unknown / Feb 05, 2020 | |
Junten Bio
|
JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine. | $1.8M / Dec 17, 2018 | |
HIROTSU BIO SCIENCE
|
HIROTSU BIO SCIENCE is a biotechnology company. | $198.4M / Aug 06, 2018 |
Co-Investors
Miraca Holdings
4 deals together
As One
1 deal together
Avex
1 deal together
BiGEN
1 deal together
Daishi Bank
1 deal together
DCI Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does H.U. Group Central Research Institute invest in?
H.U. Group Central Research Institute invests primarily in Medical, Health Care and Apps startups, most often at Venture - Series Unknown and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact H.U. Group Central Research Institute?
Public channels for H.U. Group Central Research Institute include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at H.U. Group Central Research Institute?
The team at H.U. Group Central Research Institute includes Shigekazu Takeuchi (Chairman, President, and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
